All Comments by Paul Coleman

  1. Brain volume preserved in healthy elderly through the eleventh decade.
  2. Short-term administration of selegiline for mild-to-moderate dementia of the Alzheimer's type.
  3. Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients.
  4. Presenilins and Alzheimer's disease: the role of A beta 42.
  5. Pyramidal neuron loss is matched by ghost tangle increase in Guam parkinsonism-dementia hippocampus.
  6. Cholinergic markers in elderly patients with early signs of Alzheimer disease.
  7. Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain.
  8. Hippocampal volume in patients with alcohol dependence.
  9. Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease.
  10. Quantification of cholinergic and select non-cholinergic mesopontine neuronal populations in the human brain.
  11. A test of odor fluency in patients with Alzheimer's and Huntington's disease.
  12. Hyperphosphorylated tau in SY5Y cells: similarities and dissimilarities to abnormally hyperphosphorylated tau from Alzheimer disease brain.
  13. Multivariate analysis of laminar patterns of neurodegeneration in posterior cingulate cortex in Alzheimer's disease.
  14. Link Between Education Level and AD Risk Strengthened